Governance is key to controlling SARS-CoV-2’s vaccine resistance
View ORCID ProfileKenichi W. Okamoto, View ORCID ProfileLuis F. Chaves, Rodrick Wallace, Robert G. Wallace
doi: https://doi.org/10.1101/2022.05.26.22275649
Kenichi W. Okamoto
1Department of Biology, University of St. Thomas, St Paul, USA
Luis F. Chaves
2Instituto Conmmemorativo Gorgas de Estudios de la Salud, Ciudad de Panama, Panama
Rodrick Wallace
3Department of Epidemiology, New York State Psychiatric Institute, New York City, USA
Robert G. Wallace
4Agroecology and Rural Economics Research Corps, St Paul, USA
Posted May 30, 2022.
Governance is key to controlling SARS-CoV-2’s vaccine resistance
Kenichi W. Okamoto, Luis F. Chaves, Rodrick Wallace, Robert G. Wallace
medRxiv 2022.05.26.22275649; doi: https://doi.org/10.1101/2022.05.26.22275649
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (201)
- Cardiovascular Medicine (2936)
- Dermatology (249)
- Emergency Medicine (439)
- Epidemiology (12741)
- Forensic Medicine (12)
- Gastroenterology (827)
- Genetic and Genomic Medicine (4579)
- Geriatric Medicine (417)
- Health Economics (729)
- Health Informatics (2914)
- Health Policy (1069)
- Hematology (388)
- HIV/AIDS (924)
- Medical Education (425)
- Medical Ethics (115)
- Nephrology (468)
- Neurology (4348)
- Nursing (236)
- Nutrition (638)
- Oncology (2268)
- Ophthalmology (645)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (501)
- Pediatrics (1196)
- Primary Care Research (496)
- Public and Global Health (6932)
- Radiology and Imaging (1527)
- Respiratory Medicine (915)
- Rheumatology (437)
- Sports Medicine (385)
- Surgery (487)
- Toxicology (60)
- Transplantation (210)
- Urology (180)